Top Markets
Coin of the day
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rangering i aksjer #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Aksjekurs
$2.22
Sist synkronisert: 2026-08-21
Markedsverdi
$117.70M
Endring (1 dag)
2.69%
Endring (1 år)
17.26%
Land
SE
Handel SynAct Pharma AB (SYNACT)

Kategori

Historikk for aksjesplitt for SynAct Pharma AB (SYNACT)
Aksjen SynAct Pharma AB (symbol: SYNACT) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 24, 2026.
Én SYNACT-aksje kjøpt før Aug 24, 2026 tilsvarer i dag 0 SYNACT-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH